RegeneRx Biopharmaceuticals (RGRX) Cash flow

82 Followers

RegeneRx Biopharmaceuticals Cash Flow

RGRX's free cash flow for Q1 2023 was $-189.33K. For the 2023 fiscal year, RGRX's free cash flow was decreased by $49.58K and operating cash flow was $-189.33K. See a summary of the company’s cash flow.

Cash Flow	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Operating Cash Flow	$ -940.72K	$ -990.30K	$ -1.01M	$ -1.14M	$ -888.29K
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 0.00	$ 1.79M	$ 794.91K	$ 1.54M	$ 943.85K
End Cash Position	$ 290.89K	$ 1.23M	$ 427.90K	$ 639.92K	$ 237.26K
Free Cash Flow	$ -940.72K	$ -990.30K	$ -1.01M	$ -1.14M	$ -888.29K

Currency in USD